Avisan (Tablets) Instructions for Use

Marketing Authorization Holder

Vifitech, CJSC (Russia)

ATC Code

G04BD (Drugs for the treatment of frequent urination and urinary incontinence)

Dosage Form

Avisan

Coated tablets 50 mg: 20, 25, 30, or 50 pcs.

Dosage Form, Packaging, and Composition

Coated tablets yellow in color, round, biconvex in shape.

Excipients : powdered sugar (sucrose), basic magnesium carbonate (magnesium hydroxycarbonate), potato starch, talc, calcium stearate.

Shell composition powdered sugar (sucrose), talc, basic magnesium carbonate (magnesium hydroxycarbonate), pigment titanium dioxide (titanium dioxide), low molecular weight medical polyvinylpyrrolidone (povidone), glycerol (glycerin), dye tropaeolin O, beeswax, vaseline oil (liquid paraffin).

10 pcs. – contour cell packs (2) – cardboard packs.
10 pcs. – contour cell packs (3) – cardboard packs.
10 pcs. – contour cell packs (5) – cardboard packs.
25 pcs. – dark glass jars (1) – cardboard packs.

Clinical-Pharmacological Group

Drug reducing the tone of the smooth muscles of the urinary tract

Pharmacotherapeutic Group

Spasmolytic agent of plant origin

Pharmacological Action

Spasmolytic agent, selectively acts on the smooth muscles of the ureters.

Reduces or relieves pain in patients with renal colic and facilitates the passage of calculi through the urinary tract.

Reduces dysuric phenomena.

Indications

• Renal colic
• Spasm of the ureters
• Nephrourolithiasis
• Cystitis
• Ureteral catheterization

Use for the symptomatic relief of smooth muscle spasm in the urinary tract.

ICD codes

Dosage Regimen

Administer orally. The standard adult dosage is 50-100 mg taken three to four times daily.

Take tablets after meals to improve gastrointestinal tolerance. The typical course of treatment lasts from 1 to 3 weeks.

Adverse Reactions

Adverse reactions are generally mild and primarily involve the gastrointestinal system.

Observe for dyspeptic phenomena, such as nausea, epigastric discomfort, or heartburn. These effects are typically dose-related and may subside with continued use.

Contraindications

• Hypersensitivity to the active substance (dry extract of Ammi visnaga) or to any of the excipients listed in the composition.

Do not use in patients with a known history of allergic reaction to this product or its components.

Drug Interactions

Formal drug interaction studies have not been conducted. Exercise caution with concomitant use of other spasmolytic agents due to the potential for additive effects on smooth muscle relaxation.

Monitor for enhanced therapeutic and adverse effects when used with other drugs affecting urinary tract motility.

Overdose

Symptoms of overdose may include an exacerbation of adverse reactions, particularly severe gastrointestinal discomfort.

In case of suspected overdose, discontinue use immediately and institute supportive measures. Gastric lavage and administration of activated charcoal may be considered if ingestion was recent.

There is no specific antidote; provide symptomatic and supportive treatment.

Special Precautions

To facilitate the removal of stones, a large amount of fluid is recommended – 1.5-2 liters orally over 2-3 hours.

Storage Conditions

Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.

Dispensing Status

Over-the-Counter

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.